BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12060035)

  • 1. Barrett's esophagus: so what!
    van Blankenstein M
    Dis Esophagus; 2002; 15(1):1-4. PubMed ID: 12060035
    [No Abstract]   [Full Text] [Related]  

  • 2. Barrett's esophagus and cancer risk: a more realistic estimate.
    Rajendra S; Sharma P
    Semin Thorac Cardiovasc Surg; 2011; 23(4):261-2. PubMed ID: 22443641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal capsule endoscopy for Barrett's esophagus screening: a hard pill to swallow?
    Hur C
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):307-9. PubMed ID: 17257904
    [No Abstract]   [Full Text] [Related]  

  • 4. Occult adenocarcinoma after esophagectomy for Barrett's high-grade dysplasia.
    Donnellan F; Harewood GC; Patchett SE
    Gastrointest Endosc; 2010 Feb; 71(2):429. PubMed ID: 20152322
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of adenocarcinoma in Barrett's oesophagus: population based study.
    Murray L; Watson P; Johnston B; Sloan J; Mainie IM; Gavin A
    BMJ; 2003 Sep; 327(7414):534-5. PubMed ID: 12958113
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-grade dysplasia in Barrett's esophagus.
    Odze RD; Goldblum JR
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1419-20; author reply 1420. PubMed ID: 17110303
    [No Abstract]   [Full Text] [Related]  

  • 7. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
    Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.
    de Jonge PJ; van Blankenstein M; Looman CW; Casparie MK; Meijer GA; Kuipers EJ
    Gut; 2010 Aug; 59(8):1030-6. PubMed ID: 20639249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.
    Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ;
    Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Barrett's carcinoma of the esophagus.
    Hölscher AH; Vallböhmer D; Bollschweiler E
    Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for Barrett's esophagus.
    Zakko L; Lutzke L; Wang KK
    Minerva Med; 2017 Feb; 108(1):28-42. PubMed ID: 27792223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated.
    Curvers WL; ten Kate FJ; Krishnadath KK; Visser M; Elzer B; Baak LC; Bohmer C; Mallant-Hent RC; van Oijen A; Naber AH; Scholten P; Busch OR; Blaauwgeers HG; Meijer GA; Bergman JJ
    Am J Gastroenterol; 2010 Jul; 105(7):1523-30. PubMed ID: 20461069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
    Provenzale D; Schmitt C; Wong JB
    Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of cancer risk in Barrett's esophagus.
    Tan A; Macrae F
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1485-92. PubMed ID: 21592226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
    O'Connor JB; Falk GW; Richter JE
    Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of dysplastic Barrett's esophagus: where do we go from here?
    Peters JH
    Ann Surg Oncol; 2002 Apr; 9(3):215-6. PubMed ID: 11923124
    [No Abstract]   [Full Text] [Related]  

  • 18. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
    Corey KE; Schmitz SM; Shaheen NJ
    Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic diagnosis of subsquamous invasion of adenocarcinoma in short-segment Barrett's esophagus.
    Takahashi A; Oyama T
    Dig Endosc; 2017 Apr; 29 Suppl 2():38-39. PubMed ID: 28425664
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term endoscopic surveillance of Barrett's esophagus.
    Sampliner RE
    Am J Gastroenterol; 2003 Sep; 98(9):1912-3. PubMed ID: 14499764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.